Results 41 to 50 of about 19,181 (247)

The Value of Adrenal Androgens for Correcting Cortisol Lateralization in Adrenal Venous Sampling in Patients with Normal Cortisol Secretion

open access: yesInternational Journal of Endocrinology, 2019
The management of patients with adrenocorticotropic hormone-independent Cushing’s syndrome and bilateral adrenal masses is challenging. Adrenal venous sampling (AVS) has been used to identify functional lesions in previous studies, but it is not always ...
Wenjing Zhang   +6 more
doaj   +1 more source

Model-Informed Target Morning 17α-Hydroxyprogesterone Concentrations in Dried Blood Spots for Pediatric Congenital Adrenal Hyperplasia Patients

open access: yesPharmaceuticals, 2023
Monitoring cortisol replacement therapy in congenital adrenal hyperplasia (CAH) patients is vital to avoid serious adverse events such as adrenal crises due to cortisol underexposure or metabolic consequences due to cortisol overexposure.
Viktoria Stachanow   +11 more
doaj   +1 more source

Nuclear imaging in the diagnosis of primary aldosteronism. [PDF]

open access: yes, 2015
PURPOSE OF REVIEW: Primary aldosteronism is increasingly recognized as a common secondary cause of hypertension. Successful demonstration of a unilateral cause (e.g. a classical 'Conn's adenoma') offers the potential for curative adrenalectomy.
Brown, Morris J   +2 more
core   +2 more sources

Factors Associated with Resolution of Hypertension after Adrenalectomy in Patients with Primary Aldosteronism [PDF]

open access: yesEndocrinology and Metabolism, 2018
BackgroundThe aim of this study was to investigate the factors associated with resolution of hypertension after adrenalectomy in patients with primary aldosteronism.
Wann Jia Loh   +3 more
doaj   +1 more source

Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism [PDF]

open access: yes, 2010
Surgically correctable forms of primary aldosteronism are characterized by unilateral aldosterone hypersecretion and renin suppression, associated with varying degrees of hypertension and hypokalemia. Unilateral aldosterone hypersecretion is caused by an
Laurence Amar   +2 more
core   +1 more source

Diagnostic criteria for adrenal venous sampling

open access: yesCurrent Opinion in Endocrinology, Diabetes & Obesity, 2016
Primary aldosteronism accounts for 3 to 5% of all hypertension cases. Unilateral aldosterone hypersecretion can be treated with adrenalectomy. Guidelines for primary aldosteronism management recommend adrenal vein sampling (AVS) to ascertain unilateral primary aldosteronism before surgery.
Steichen, Olivier, Amar, Laurence
openaire   +3 more sources

Adrenal venous sampling: cosyntropin stimulation or not? [PDF]

open access: yesEuropean Journal of Endocrinology, 2019
Notwithstanding the high prevalence of primary aldosteronism (PA), probably the most common form of secondary hypertension, the diagnosis of PA is often neglected or delayed, thus precluding target treatment, which is curative in many cases. For selection of the most appropriate treatment, a fundamental step is the distinction between a lateralized ...
Deinum, Jaap   +4 more
openaire   +4 more sources

Imaging Analysis During Adrenal Venous Sampling Operations

open access: yesAmerican Journal of Hypertension, 2021
Abstract Background To investigate the imaging anatomy and variations of bilateral adrenal veins to improve the success rate during adrenal venous sampling (AVS) and reduce the incidence of complications.
Sen Li   +8 more
openaire   +1 more source

A case of primary aldosteronism with resistant hypertension successfully treated by unilateral adrenalectomy after unsuccessful classification of subtype in adrenal venous sampling

open access: yesClinical Case Reports, 2019
Despite being an established method to identify the unilateral subtype of primary aldosteronism with an indication of adrenalectomy, adrenal venous sampling sometimes fails primarily due to unsuccessful cannulation to adrenal veins.
Ryo Nakamaru   +15 more
doaj   +1 more source

Generation and characterization of a mitotane-resistant adrenocortical cell line [PDF]

open access: yes, 2020
Mitotane is the only drug approved for the therapy of adrenocortical carcinoma (ACC). Its clinical use is limited by the occurrence of relapse during therapy.
Bachmann, Sebastian   +14 more
core   +2 more sources

Home - About - Disclaimer - Privacy